The Health Care Cost Monitor is made possible by Supporting Members of The Hastings Center. Please give today.
-
Recent Posts
Connect with Us
Weekly Email Alerts
Print Edition
Contributors
- Adam Oliver
- Alain Enthoven
- Andrew G. Biggs
- Anthony Marfeo
- Barbara Starfield, M.D.
- Blair L. Sadler
- Dan Brock
- Daniel Callahan
- David Durenberger
- Eric Cassell, M.D.
- Eugene Cauvin
- Hans Maarse
- Henry J. Aaron
- J. Wesley Boyd
- Jacqueline R. Fox
- John Geyman, M.D.
- Joseph White
- Joshua Boger
- Joshua T. Cohen
- Kimberly Swartz
- Kristin Voigt
- Leonard Fleck
- Louise B. Russell
- Margaret Davino
- Mark Helfand
- Muriel R. Gillick, M.D.
- Norman Daniels
- Paul T. Menzel
- Peter A. Ubel, M.D.
- Polo Black Golde
- Richard A. Cooper, M.D.
- Richard B. Saltman
- Ruth Faden
- Sharon R. Kaufman
- Solomon R. Benatar
- Steven Pearson, M.D.
- Susan Bartlett Foote
- Susan Gilbert
- The Editors
- Theodore Marmor
Subjects
Blogroll
- Bioethics Forum
- CBO Director's Blog
- Gooznews
- Health Affairs Blog
- Health Care Organizational Ethics
- Health Policy and Communications Blog
- Health Populi
- Health Wonk Review
- Insureblog
- Kaiser Network
- Managed Care Matters
- National Journal Expert Blog on Health Care
- Physicians for a National Health Program
- Prescriptions Blog
- Robert Wood Johnson Foundation
- The Commonwealth Fund
- The Fiscal Times
- The Health Care Blog
- The New Health Dialogue
- The New Old Age
- Wall Street Journal Health Blog
Support
The Health Care Cost Monitor is made possible by Supporting Members of The Hastings Center.
Please consider supporting the Center today with a tax-deductible donation.





Proust on Treating Chronic Disease
How to control the astronomical costs of treating chronic diseases is a modern economic and political problem. But when to limit treatment is an enduring literary one.
The need to control health care cost came up repeatedly in President Obama’s health care reform summit last week, although there was barely a mention of one of the main drivers of those costs: chronic diseases. Seventy-six percent of Medicare spending is on patients with five or more chronic diseases, including heart disease, metabolic syndrome, end-stage renal disease, and cancer. Treatment usually doesn’t lead to a cure, but it does tend to extend patients’ lives.
Prolonging life is one of the triumphs of medicine when the result is reasonably good health. But often costly treatments for chronic diseases simply prolong the dying process, inevitably raising difficult questions about setting limits. “It is a great miracle that medicine can almost equal nature in forcing a man to remain in bed, to continue on pain of death the use of some drug.” That statement would not have been out of place at the health care reform summit, but it was written by Marcel Proust in 1923 in Remembrances of Things Past: Volume III – The Captive, The Fugitive, Time Regained. The rest of the passage, which follows, resonates today.